Laminin alpha 4 Antibody (839084) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # FAB7340D
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 839084
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Chinese hamster ovary cell line CHO-derived recombinant human Laminin alpha4
Arg826-Ser1816
Accession # Q16363
Arg826-Ser1816
Accession # Q16363
Specificity
Detects human Laminin alpha4 in ELISAs.
In direct ELISAs, no cross-reactivity with
recombinant mouse Laminin alpha 4 or recombinant human Laminin alpha 3 is
observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Laminin alpha 4 Antibody (839084) [DyLight 350]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Laminin alpha 4
Alternate Names
LAMA4
Gene Symbol
LAMA4
Additional Laminin alpha 4 Products
Product Documents for Laminin alpha 4 Antibody (839084) [DyLight 350]
Product Specific Notices for Laminin alpha 4 Antibody (839084) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...